It seems that a drug that is actually approved for treatment of the dermal disorder psoriasis stimulates the activity of the enzyme ADAM10 in the brain of Alzheimer’s patients. It is estimated that about 35 million people worldwide currently suffer from dementia and it is expected that the number will increase to 135 million by the year 2050. Currently, there is no cure.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/tzC5ipccXHo/141208093246.htm
New approach for treating Alzheimer’s disease: Psoriasis drug
8 diciembre 2014
Volver